The 5 Most Shorted NYSE Stocks as Q2 Begins

Print Email

Rising short interest in Petrobras kept its shares firmly in ranks of the most shorted stocks trading on the New York Stock Exchange between the March 31 and April 15 settlement dates. On the other hand, short sellers continued to give up on Pfizer, allowing it to drop out of the top five.

All of the top five had more than 110,000 shares short at the end of the most recent two-week settlement period.

The number of AT&T Inc. (NYSE: T) shares short decreased marginally in the first two weeks of the month, but the stock remains at the top of the list. The more than 318.68 million shares short represent 6.1% of the float. It would take about 12 days to cover all short positions. Note that this was the first decline in short interest since last September. Credit Suisse talked up the stock during the period. Shares were essentially flat in the two weeks to April 15. The stock closed Friday at $34.01, which was 1.3% higher than at the beginning of the year. The 52-week trading range is $32.07 to $37.48.

There was a 5.1% gain in the short interest in Vale S.A. (NYSE: VALE) during the period. That took back most of the decline in the previous period, and it brought the number of shares short to more than 224.50 million, which was the second highest level in the past year. It was also about 7% of the float. At the current average daily volume, it would take around nine days to cover all short positions. Vale’s shares rose 6.9% during the two-week short-interest period. They have surged about 29% since, though. Shares closed most recently at $7.92, in a 52-week range of $5.45 to $14.93.

ALSO READ: The 5 Most Shorted Nasdaq Stocks as Q2 Begins